Back to Search
Start Over
Capnocytophaga bacteraemia following rituximab treatment.
- Source :
-
BMJ case reports [BMJ Case Rep] 2012 Aug 13; Vol. 2012. Date of Electronic Publication: 2012 Aug 13. - Publication Year :
- 2012
-
Abstract
- A case is presented of Capnocytophaga bacteraemia, in a juvenile chronic arthritis (JCA) patient receiving steroids, methotrexate and rituximab. This Gram-negative bacillus commonly found in dog saliva has been described to cause illness in immune compromised hosts such as oncology patients, those receiving cytotoxic or biological drugs, alcoholics or postsplenectomy. To the best of our knowledge, this is the first report of Capnocytophaga bacteraemia following rituximab treatment.
- Subjects :
- Anti-Bacterial Agents therapeutic use
Arthritis, Juvenile drug therapy
Arthritis, Juvenile immunology
Bacteremia drug therapy
Bacteremia immunology
Female
Gram-Negative Bacterial Infections drug therapy
Gram-Negative Bacterial Infections immunology
Humans
Immunocompromised Host
Rituximab
Young Adult
Antibodies, Monoclonal, Murine-Derived adverse effects
Antirheumatic Agents adverse effects
Bacteremia microbiology
Capnocytophaga
Gram-Negative Bacterial Infections microbiology
Subjects
Details
- Language :
- English
- ISSN :
- 1757-790X
- Volume :
- 2012
- Database :
- MEDLINE
- Journal :
- BMJ case reports
- Publication Type :
- Academic Journal
- Accession number :
- 22891017
- Full Text :
- https://doi.org/10.1136/bcr-2012-006224